<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04949477</url>
  </required_header>
  <id_info>
    <org_study_id>8-5-2021</org_study_id>
    <nct_id>NCT04949477</nct_id>
  </id_info>
  <brief_title>Intranasal Dexmedetomidine Versus Oral Paracetamol as a Pre-anaesthetic Medication in Pediatric Age Group</brief_title>
  <official_title>Intranasal Dexmedetomidine Versus Oral Paracetamol as a Pre-anaesthetic Medication in Pediatric Age Group Undergoing Adenotonsillectomy: A Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-operative anxiety is a major problem in children because it produces undesired results on&#xD;
      induction and postoperative outcome. Dexmedetomidine is a highly specific alpha 2 adrenergic&#xD;
      receptor agonist. Studies suggest that Dexmetomidine administration is safe as it is less&#xD;
      invasive and have a short half-life.&#xD;
&#xD;
      Paracetamol is a potent physical pain killer. It also reduces psychological reactivity and&#xD;
      blunts physical and social pain.&#xD;
&#xD;
      Adenotonsillectomy is one of the most common surgeries performed in pediatric age groups, so&#xD;
      it is important to reduce pre-operative anxiety in those children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-operative anxiety is a major problem in children because it produces undesired results on&#xD;
      induction and postoperative outcome. Dexmedetomidine is a highly specific alpha 2 adrenergic&#xD;
      receptor agonist. Studies suggest that Dexmetomidine administration is safe as it is less&#xD;
      invasive and have a short half-life.&#xD;
&#xD;
      Paracetamol is a potent physical pain killer. It also reduces psychological reactivity and&#xD;
      blunts physical and social pain.&#xD;
&#xD;
      Adenotonsillectomy is one of the most common surgeries performed in pediatric age groups, so&#xD;
      it is important to reduce pre-operative anxiety in those children.&#xD;
&#xD;
      The objective of this descriptive study is to compare the efficacy of dexmedetomidine and&#xD;
      paracetamol premedication, measuring the degree of anxiety in the children prepared for&#xD;
      adenotonsillectomy when they are separated from their parents.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preoperative anxiety</measure>
    <time_frame>After 50 minutes of drug administration.</time_frame>
    <description>Modified Yale preoperative anxiety score (m-Yale PAS) before intravenous catheterization. In m-Yale PAS, anxiety was assessed based on their activities, (1-4) emotional expression, (1-4) Vocalization, (1-6) state of arousal (1-4) and interaction with family members.(1-4) The minimum of score is five (minimum anxiety) and the maximum is 22 which means severe anxiety.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Group (D)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patient will receive intranasal dexmedetomidine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (P)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patient will receive paracetamol orally.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>the patient will receive intranasal dexmedetomidine at a dose of 1 μg/kg to the patient 45 min. before the procedure.</description>
    <arm_group_label>Group (D)</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>the patient will receive paracetamol orally [Rx paracetamol 250 mg/ml] at a dose of 20 mg/kg given to the patient 45 min before the procedure by drinking.</description>
    <arm_group_label>Group (P)</arm_group_label>
    <other_name>cetal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patients who are clinically free or with controlled medical condition [ASA I or&#xD;
             ASA II].&#xD;
&#xD;
          -  Age between 2 to 8 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA III or ASA IV.&#xD;
&#xD;
          -  Age greater than 8 years.&#xD;
&#xD;
          -  Parents' refusal to participate in the study.&#xD;
&#xD;
          -  Patients with obstructive sleep apnea.&#xD;
&#xD;
          -  Patients with known allergy or hypersensitivity reaction to any of the drugs used in&#xD;
             the study.&#xD;
&#xD;
          -  Patients with nasal infection or nasal pathology.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>fatma ahmed abdelfatah, MD</last_name>
    <phone>00201027011148</phone>
    <phone_ext>01000607978</phone_ext>
    <email>drfatmaahmed86@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banha Faculity of Medicine</name>
      <address>
        <city>Banhā</city>
        <state>Elqalyoubea</state>
        <zip>13511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>fatma ahmed abdelfatah, MD</last_name>
      <phone>0020102011148</phone>
      <phone_ext>01000607978</phone_ext>
      <email>drfatmaahmed86@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 25, 2021</study_first_submitted>
  <study_first_submitted_qc>July 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Fatma Ahmed Abdel Fatah</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Paracetamol</keyword>
  <keyword>Preoperative anxiety</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

